Skip to main content
. 2020 Nov 6;12:11333–11340. doi: 10.2147/CMAR.S279096

Table 5.

Lists the Details of Treatment-Related Toxicities

Toxicities Combination Therapy Group (n=76) Target Drug Group (n=72)
Grade 1 or 2 Grade 3 or 4 Grade 1 or 2 Grade 3 or 4
Rash 25(32.9) 3(3.9) 24(33.3) 2(2.8)
Elevated ALT/AST 18(23.7) 1(1.3) 17(23.6) 0
Diarrhea 16(21.1) 1(1.3) 15(20.8) 1(1.4)
Dizziness 15(19.7) 0 1(1.3) 0
Fatigue 14(18.4) 0 13(18.1) 0
Headache 14(18.4) 0 1(1.3) 0
Nausea 9(11.8) 0 7(9.7) 0
Vomiting 6(7.9) 0 5(6.9) 0
Leukopenia 5(6.6) 0 4(5.5) 0
Cognitive disorder 4(5.3) 0 0 0